TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE DEEP BRAIN STIMULATION SYSTEMS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.10 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 EPIDEMIOLOGY
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING CASES OF NEUROLOGICAL DISORDERS
6.1.2 GROWING ACCEPTANCE OF MINIMALLY INVASIVE PROCEDURES
6.1.3 RISE IN NUMBER OF PRODUCTS SEEKING APPROVAL
6.1.4 IMPROVES QUALITY OF LIFE AND REDUCES THE DISEASE SYMPTOMS
6.2 RESTRAINTS
6.2.1 HIGH COST OF DEEP BRAIN STIMULATION DEVICES AND SURGERY
6.2.2 STRICT REGULATIONS
6.2.3 POST-OPERATIVE LIMITATIONS OF DEEP BRAIN STIMULATION SYSTEMS
6.3 OPPORTUNITIES
6.3.1 ADVANCEMENT IN NOVEL TECHNOLOGIES
6.3.2 INCREASING HEALTHCARE EXPENDITURE FOR NEUROLOGICAL DISORDERS
6.3.3 MEDICAL TOURISM
6.3.4 EMERGING ECONOMY
6.4 CHALLENGES
6.4.1 HIGH RISK AND COMPLICATIONS OF DEEP BRAIN STIMULATION SURGERY
6.4.2 LOW ACCEPTANCE AMONG PATIENTS
6.4.3 MALFUNCTION OF THE STIMULATOR
7 EUROPE DEEP BRAIN STIMULATION SYSTEMS MARKET, BY PRODUCT TYPE
1.1. OVERVIEW
7.1.1 SINGLE-CHANNEL DEEP BRAIN STIMULATOR
7.1.2 DUAL CHANNEL DEEP BRAIN STIMULATOR
8 EUROPE DEEP BRAIN STIMULATION SYSTEMS MARKET, BY APPLICATION
8.1 OVERVIEW
8.1.1 PARKINSON'S DISEASE
8.1.2 ESSENTIAL TREMOR
8.1.3 DYSTONIA
8.1.4 EPILEPSY
8.1.5 OBSESSIVE-COMPULSIVE DISORDER
9 EUROPE DEEP BRAIN STIMULATION SYSTEMS MARKET, BY TYPE
9.1 OVERVIEW
9.1.1 RECHARGEABLE
9.1.2 NON-RECHARGEABLE
10 EUROPE DEEP BRAIN STIMULATION SYSTEMS MARKET, BY END USER
10.1 OVERVIEW
10.1.1 HOSPITALS
10.1.2 NEUROLOGICAL CLINIC
10.1.3 AMBULATORY SURGICAL CENTERS (ASC'S)
?
11 EUROPE DEEP BRAIN STIMULATION SYSTEMS MARKET, BY GEOGRAPHY
11.1 EUROPE
11.1.1 GERMANY
11.1.2 FRANCE
11.1.3 U.K.
11.1.4 ITALY
11.1.5 SPAIN
11.1.6 SWITZERLAND
11.1.7 RUSSIA
11.1.8 NETHERLAND
11.1.9 BELGIUM
11.1.10 TURKEY
11.1.11 REST OF EUROPE
12 EUROPE DEEP BRAIN STIMULATION SYSTEMS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 COMPANY PROFILE
13.1 MEDTRONIC
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENT
13.2 BOSTON SCIENTIFIC CORPORATION
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 ABBOTT
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENT
13.4 ALEVA NEUROTHERAPEUTICS SA
13.4.1 COMPANY SNAPSHOT
13.4.2 PRODUCT PORTFOLIO
13.4.3 RECENT DEVELOPMENT
13.5 NEUROPACE, INC.
13.5.1 COMPANY SNAPSHOT
13.5.2 PRODUCT PORTFOLIO
13.5.3 RECENT DEVELOPMENT
13.6 BEIJING PINS MEDICAL CO., LTD.
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENT
13.7 SCENERAY CORPORATION, LIMITED
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
13.8 FISHER WALLACE
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENT
14 SWOT ANALYSIS
15 QUESTIONNAIRE
16 RELATED REPORTS